Claire Jenkinson

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

Darragh P. O’Brien, Neomal S. Sandanayake, Claire Jenkinson et al. · Clinical Cancer Research · 2014 · 198 citations · Full text

Medicine, Oncology, Pathology +14

A comparison of the performance of the EQ‐5D and SF‐6D for individuals aged ≥ 45 years

Garry Barton, Tracey Sach, Anthony Avery et al. · Health Economics · 2007 · 116 citations

Medicine, Geriatric Medicine, Geriatric Assessment +9

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

Claire Jenkinson, Victoria L. Elliott, A.G. Evans et al. · Clinical Cancer Research · 2015 · 86 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?

Garry Barton, Tracey Sach, Claire Jenkinson et al. · Health and Quality of Life Outcomes · 2008 · 85 citations · Full text

Pharmacy, Orthopedic Surgery, Pharmacoeconomics +17

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease

Victoria Shaw, Brian Lane, Claire Jenkinson et al. · Molecular Cancer · 2014 · 85 citations · Full text

Medicine, Biostatistics, Oncology +17